Clinical Trial Update: Sildenafil for Microvasculopathy in Chronic TBI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sildenafil for microvasculopathy in adults with chronic traumatic brain injury, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University of Pennsylvania | Conditions: Traumatic Brain Injury | Phase 2 | Status: RECRUITING